Key names in the list include HCL Technologies, Tech Mahindra, Maruti Suzuki India, Hindustan Unilever, Axis Bank, Nestle India, IDFC First Bank, India Cements, LT Finance, Tata Technologies ...

Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.

Indicator pen and Bottle representing alcohol Source: Generated with AI ∙ DALL-E image Creator Mechanism of Action Relevant to AUD GLP-1 is an incretin hormone that influences insulin secretion ...

including more familiarity with the incretin therapies by the time of tirzepatide approval.” And, Galindo added, tirzepatide generally has been shown to have higher glucose-lowering potency than ...

“We’ll be ready.” Lilly is studying orforglipron and its other medicines, a class of drugs called incretins, in range of conditions related to metabolic health. Ricks said that maintaining a ...

Modern research now confirms that bitter compounds stimulate the release of incretin hormones, which enhance insulin secretion in response to meals. This effect may help flatten postprandial blood ...

GLP-1 treatment developers should fare better with investors, Hsieh observed, than developers of peptide-based incretin drugs for diabetes and obesity. Those include the Terns Pharmaceuticals ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...